Bellevue Group AG boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,091,000 shares of the company’s stock after purchasing an additional 369,500 shares during the period. Revolution Medicines […]
Bain Capital Life Sciences Investors LLC bought a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines comprises 3.1% of Bain Capital Life […]
Bain Capital Life Sciences Investors LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines accounts for 3.1% of Bain Capital Life […]
Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 6,800 shares, a decline of 29.9% from the April 30th total of 9,700 shares. Based on an average daily trading volume, of 1,800 […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been given an average rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]